NASDAQ:ELVN | Profit Breakdown | Enliven Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$37.21M-$32.49M
2026-03-31-$27.82M-$23.63M
2025-12-31-$34.29M-$29.67M
2025-09-30-$25.1M-$20.15M
2025-06-30-$28.58M-$25.34M
2025-03-31-$31.69M-$28.54M
2024-12-31-$26.9M-$23.18M
2024-09-30-$27.07M-$23.16M
2024-06-30-$24.6M-$19.95M
2024-03-31-$25.99M-$22.74M
2023-12-31-$22.73M-$19.37M
2023-09-30-$24.25M-$20.77M
2023-06-30-$20.13M-$16.72M
2023-03-31-$16.42M-$14.72M
2022-12-31-$10.16M-$9.55M
2022-09-30-$10.93M-$10.55M
2022-06-30-$9.02M-$8.89M
2022-03-31-$8.68M-$8.67M
2021-12-31-$14.33M-$14.32M
2021-09-30-$13.66M-$13.65M
2021-06-30-$13.17M-$13.16M
2021-03-31-$10.28M-$10.26M
2020-12-31-$11.55M-$11.52M
2020-09-30-$12.49M-$12.42M
2020-06-30-$10.3M-$10.2M
2020-03-31-$7.35M-$7.22M
2019-12-31-$7.48M-$7.25M
2019-09-30-$6.88M-$6.62M
2019-06-30-$5.56M-$5.4M
2019-03-31-$4.19M-$4.19M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$119.66M-$103.69M
2024-12-31-$104.55M-$89.02M
2023-12-31-$83.53M-$71.58M
2022-12-31-$38.79M$1.58M-$37.66M
2021-12-31-$51.44M-$51.38M-$51.38M
2020-12-31-$41.7M-$41.36M
2019-12-31-$24.12M-$23.46M